| Document Date: 2013-12-12 16:36:16
Open Document File Size: 62,11 KBShare Result on Facebook
City LENOIR / / Company STALLERGENES / Laboratories Inc. / GREER / Bloomberg / / Continent North America / Europe / / Country Russia / United States / Canada / Australia / / Currency EUR / / / Event FDA Phase / Business Partnership / / IndustryTerm biopharmaceutical / treatment of allergy / manufacturing / allergy immunotherapy products / product / / MedicalCondition allergic asthma / common seasonal allergy / rhinitis / allergy / sublingual allergy / conjunctivitis / allergy-related respiratory diseases / Grass Pollen Allergy LENOIR / oral pruritus / throat irritation / / MedicalTreatment immunotherapy / allergen immunotherapy / / Organization U.S. Food and Drug Administration / FDA / Allergenic Products Advisory Committee / / Person John G. Roby / Andrea Moody / / / Position leader / president and CEO / General / / Product ORALAIR® / Europe / / ProvinceOrState North Carolina / / Technology antibodies / / URL http /
SocialTag |
Press Release Contact: Andrea Moody Phone: [removed]Email: [removed]